Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 075 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 075 IN PLASTIC CONTAINER.
DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER vs DEXTROSE 5% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides glucose for cellular energy metabolism. Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity for metabolic acidosis.
Dextrose is a monosaccharide that serves as a source of calories and water for hydration. It is metabolized to carbon dioxide and water, yielding energy. Potassium chloride dissociates to provide potassium ions, which are essential for maintenance of intracellular tonicity, nerve impulse transmission, contraction of cardiac, skeletal, and smooth muscle, and maintenance of normal renal function.
Intravenous infusion; adult dose is 500-1000 mL per 24 hours, titrated to fluid and electrolyte needs.
Intravenous infusion; rate and volume determined by patient fluid and electrolyte status. Typical maintenance: 100-125 mL/hour for adults, providing 5 g dextrose and 7.5 mEq potassium chloride per liter.
None Documented
None Documented
2–4 hours (intravenous). Clinical context: reflects glucose clearance; prolonged in renal impairment.
Potassium: terminal half-life ~1-1.5 hours in normokalemic patients; clinically relevant for dosing interval. Glucose: negligible terminal half-life due to rapid metabolism.
Renal: >99% as glucose. Biliary/fecal: negligible (<1%).
Potassium: 90% renal, 10% fecal. Glucose: completely metabolized; <1% renal.
Category C
Category C
IV Fluid
IV Fluid